- Home
- KRNY vs RNAC Comparison
KRNY vs RNAC Comparison
Compare KRNY & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRNY
- RNAC
- Stock Information
- Founded
- KRNY 1884
- RNAC 2007
- Country
- KRNY United States
- RNAC United States
- Employees
- KRNY N/A
- RNAC N/A
- Industry
- KRNY Savings Institutions
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- KRNY Finance
- RNAC Health Care
- Exchange
- KRNY Nasdaq
- RNAC Nasdaq
- Market Cap
- KRNY 444.6M
- RNAC 496.8M
- IPO Year
- KRNY 2005
- RNAC 2016
- Fundamental
- Price
- KRNY $6.82
- RNAC $19.24
- Analyst Decision
- KRNY Buy
- RNAC Strong Buy
- Analyst Count
- KRNY 2
- RNAC 8
- Target Price
- KRNY $7.75
- RNAC $41.67
- AVG Volume (30 Days)
- KRNY 335.0K
- RNAC 58.7K
- Earning Date
- KRNY 01-30-2025
- RNAC 03-06-2025
- Dividend Yield
- KRNY 6.45%
- RNAC N/A
- EPS Growth
- KRNY N/A
- RNAC N/A
- EPS
- KRNY N/A
- RNAC N/A
- Revenue
- KRNY $148,070,000.00
- RNAC $47,938,000.00
- Revenue This Year
- KRNY N/A
- RNAC $56.02
- Revenue Next Year
- KRNY $24.88
- RNAC N/A
- P/E Ratio
- KRNY N/A
- RNAC N/A
- Revenue Growth
- KRNY N/A
- RNAC N/A
- 52 Week Low
- KRNY $5.28
- RNAC $11.67
- 52 Week High
- KRNY $8.59
- RNAC $41.87
- Technical
- Relative Strength Index (RSI)
- KRNY 39.62
- RNAC 51.12
- Support Level
- KRNY $7.11
- RNAC $19.22
- Resistance Level
- KRNY $7.36
- RNAC $20.00
- Average True Range (ATR)
- KRNY 0.22
- RNAC 0.85
- MACD
- KRNY -0.02
- RNAC 0.04
- Stochastic Oscillator
- KRNY 19.23
- RNAC 67.10
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.